Position in BLLN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$947
-$35 QoQ
Shares Held
12
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BLLN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026JONES FINANCIAL COMPANIES LLLP holds $751,418,180 across 33 Diagnostics & Research names. BLLN ranks #32 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
506,040 | $248,733,840 | |
| 2 | DHR |
Danaher Corp /De/
|
699,531 | $132,631,077 | |
| 3 | LH |
Labcorp Holdings Inc.
|
366,437 | $97,769,055 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
168,195 | $80,765,556 | |
| 5 | WAT |
Waters Corp /De/
|
236,792 | $70,516,657 | |
| 6 | QGEN |
Qiagen N.V.
|
1,169,141 | $46,812,405 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
39,412 | $22,145,208 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
114,048 | $19,673,280 |
All Filings in BLLN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $947 | 12 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $982 | 12 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||